China reported only 8 new coronavirus cases Friday. 3 were imported.

China reported its second day of single-digit COVID-19 coronavirus cases in the pandemic's epicenter, the city of Wuhan, on Friday, and China's National Health Commission declared that the country's epidemic has finally peaked. There were five new cases in Wuhan on Thursday, and eight total in China, the commission said Friday. The other three cases — two in Shanghai, one in Beijing — were from people who had traveled to China from areas abroad that have their own outbreaks, the health commission said. Wuhan reported eight new cases on Wednesday, part of 15 new cases nationwide.
Mainland China has reported 80,942 coronavirus cases, including 67,786 in Hubei province, home to Wuhan. Hubei has registered 3,062 COVID-19 deaths, the bulk of the 4,728 deaths worldwide. As of Friday, there have been 128,392 cases of the coronavirus confirmed in the world since the pandemic started in January.
Still, "two months into the coronavirus epidemic in China, tens of millions of people are still under quarantine and much of the economy remains in a deep freeze," The Wall Street Journal reports. China was able to control its epidemic through strict quarantines, "mandates from central authorities against hoarding and profiteering," and heavy central planning. "It isn't clear if other countries will want to go as far as China, whose central government intervenes often in commerce," the Journal notes. But "keeping its stores filled with food and other essentials — even in hard-hit places like the city of Wuhan — [was] a crucial factor in maintaining public order throughout the crisis."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
6 grand homes in Boulder
Feature Featuring a mountain-facing balcony in Lower Chautauqua and a clover-shaped home in Flagstaff
By The Week US Published
-
Why Serbian protesters set off smoke bombs in parliament
THE EXPLAINER Ongoing anti-corruption protests erupted into full view this week as Serbian protesters threw the country's legislature into chaos
By Rafi Schwartz, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published